JP2013127477A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013127477A5 JP2013127477A5 JP2013029661A JP2013029661A JP2013127477A5 JP 2013127477 A5 JP2013127477 A5 JP 2013127477A5 JP 2013029661 A JP2013029661 A JP 2013029661A JP 2013029661 A JP2013029661 A JP 2013029661A JP 2013127477 A5 JP2013127477 A5 JP 2013127477A5
- Authority
- JP
- Japan
- Prior art keywords
- molecular
- cancer
- instructions
- analysis
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 claims 13
- -1 KIT Proteins 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 7
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 102100022307 DNA polymerase alpha catalytic subunit Human genes 0.000 claims 6
- 101000902558 Homo sapiens DNA polymerase alpha catalytic subunit Proteins 0.000 claims 6
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 claims 6
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 claims 6
- 230000014509 gene expression Effects 0.000 claims 6
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims 5
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 5
- 102100024217 CAMPATH-1 antigen Human genes 0.000 claims 5
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 claims 5
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 5
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 claims 5
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims 5
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims 5
- 229910015837 MSH2 Inorganic materials 0.000 claims 5
- 102000013609 MutL Protein Homolog 1 Human genes 0.000 claims 5
- 108010026664 MutL Protein Homolog 1 Proteins 0.000 claims 5
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims 5
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 5
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 102100025498 Proepiregulin Human genes 0.000 claims 4
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims 4
- 238000004458 analytical method Methods 0.000 claims 4
- 238000002651 drug therapy Methods 0.000 claims 4
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 4
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 4
- 238000010195 expression analysis Methods 0.000 claims 4
- 238000007901 in situ hybridization Methods 0.000 claims 4
- 230000009456 molecular mechanism Effects 0.000 claims 4
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 4
- 108010065524 CD52 Antigen Proteins 0.000 claims 3
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims 3
- 108010058546 Cyclin D1 Proteins 0.000 claims 3
- 102100024607 DNA topoisomerase 1 Human genes 0.000 claims 3
- 102100038595 Estrogen receptor Human genes 0.000 claims 3
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 claims 3
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 claims 3
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims 3
- 101000830681 Homo sapiens DNA topoisomerase 1 Proteins 0.000 claims 3
- 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 claims 3
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims 3
- 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 claims 3
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 claims 3
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 3
- 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 claims 3
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 3
- 230000002055 immunohistochemical effect Effects 0.000 claims 3
- 238000002493 microarray Methods 0.000 claims 3
- 102100036664 Adenosine deaminase Human genes 0.000 claims 2
- 102100032187 Androgen receptor Human genes 0.000 claims 2
- 102100023927 Asparagine synthetase [glutamine-hydrolyzing] Human genes 0.000 claims 2
- 108091012583 BCL2 Proteins 0.000 claims 2
- 102000052609 BRCA2 Human genes 0.000 claims 2
- 108700020462 BRCA2 Proteins 0.000 claims 2
- 101150008921 Brca2 gene Proteins 0.000 claims 2
- 102000009193 Caveolin Human genes 0.000 claims 2
- 108050000084 Caveolin Proteins 0.000 claims 2
- 102100023343 Centromere protein I Human genes 0.000 claims 2
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 claims 2
- 102000015792 Cyclin-Dependent Kinase 2 Human genes 0.000 claims 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 claims 2
- 108010009540 DNA (Cytosine-5-)-Methyltransferase 1 Proteins 0.000 claims 2
- 102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 claims 2
- 102100024812 DNA (cytosine-5)-methyltransferase 3A Human genes 0.000 claims 2
- 108010024491 DNA Methyltransferase 3A Proteins 0.000 claims 2
- 101100239628 Danio rerio myca gene Proteins 0.000 claims 2
- 102100029588 Deoxycytidine kinase Human genes 0.000 claims 2
- 101001046554 Dictyostelium discoideum Thymidine kinase 1 Proteins 0.000 claims 2
- 101150029707 ERBB2 gene Proteins 0.000 claims 2
- 101800000155 Epiregulin Proteins 0.000 claims 2
- 102100035139 Folate receptor alpha Human genes 0.000 claims 2
- 102100035144 Folate receptor beta Human genes 0.000 claims 2
- 102100027627 Follicle-stimulating hormone receptor Human genes 0.000 claims 2
- 102100040977 Follitropin subunit beta Human genes 0.000 claims 2
- 102000019448 GART Human genes 0.000 claims 2
- 102100031885 General transcription and DNA repair factor IIH helicase subunit XPB Human genes 0.000 claims 2
- 102100030943 Glutathione S-transferase P Human genes 0.000 claims 2
- 102100032812 HIG1 domain family member 1A, mitochondrial Human genes 0.000 claims 2
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 claims 2
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims 2
- 102100039996 Histone deacetylase 1 Human genes 0.000 claims 2
- 101000929495 Homo sapiens Adenosine deaminase Proteins 0.000 claims 2
- 101000975992 Homo sapiens Asparagine synthetase [glutamine-hydrolyzing] Proteins 0.000 claims 2
- 101000980814 Homo sapiens CAMPATH-1 antigen Proteins 0.000 claims 2
- 101000907944 Homo sapiens Centromere protein I Proteins 0.000 claims 2
- 101000967216 Homo sapiens Eosinophil cationic protein Proteins 0.000 claims 2
- 101001023230 Homo sapiens Folate receptor alpha Proteins 0.000 claims 2
- 101001023204 Homo sapiens Folate receptor beta Proteins 0.000 claims 2
- 101000862396 Homo sapiens Follicle-stimulating hormone receptor Proteins 0.000 claims 2
- 101000893054 Homo sapiens Follitropin subunit beta Proteins 0.000 claims 2
- 101000920748 Homo sapiens General transcription and DNA repair factor IIH helicase subunit XPB Proteins 0.000 claims 2
- 101001010139 Homo sapiens Glutathione S-transferase P Proteins 0.000 claims 2
- 101001066429 Homo sapiens HIG1 domain family member 1A, mitochondrial Proteins 0.000 claims 2
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 claims 2
- 101001078626 Homo sapiens Heat shock protein HSP 90-alpha A2 Proteins 0.000 claims 2
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 claims 2
- 101001035024 Homo sapiens Histone deacetylase 1 Proteins 0.000 claims 2
- 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 claims 2
- 101001003135 Homo sapiens Interleukin-13 receptor subunit alpha-1 Proteins 0.000 claims 2
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 claims 2
- 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 claims 2
- 101000585693 Homo sapiens Mitochondrial 2-oxodicarboxylate carrier Proteins 0.000 claims 2
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 2
- 101000961071 Homo sapiens NF-kappa-B inhibitor alpha Proteins 0.000 claims 2
- 101000979338 Homo sapiens Nuclear factor NF-kappa-B p100 subunit Proteins 0.000 claims 2
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 claims 2
- 101001041245 Homo sapiens Ornithine decarboxylase Proteins 0.000 claims 2
- 101000741790 Homo sapiens Peroxisome proliferator-activated receptor gamma Proteins 0.000 claims 2
- 101000611888 Homo sapiens Platelet-derived growth factor C Proteins 0.000 claims 2
- 101001056707 Homo sapiens Proepiregulin Proteins 0.000 claims 2
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 claims 2
- 101000712530 Homo sapiens RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 claims 2
- 101000640876 Homo sapiens Retinoic acid receptor RXR-beta Proteins 0.000 claims 2
- 101001112293 Homo sapiens Retinoic acid receptor alpha Proteins 0.000 claims 2
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 claims 2
- 101000844686 Homo sapiens Thioredoxin reductase 1, cytoplasmic Proteins 0.000 claims 2
- 101000945477 Homo sapiens Thymidine kinase, cytosolic Proteins 0.000 claims 2
- 101000809797 Homo sapiens Thymidylate synthase Proteins 0.000 claims 2
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims 2
- 101000818543 Homo sapiens Tyrosine-protein kinase ZAP-70 Proteins 0.000 claims 2
- 101000742596 Homo sapiens Vascular endothelial growth factor C Proteins 0.000 claims 2
- 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 claims 2
- 102100020791 Interleukin-13 receptor subunit alpha-1 Human genes 0.000 claims 2
- 108010091221 Lymphotoxin beta Receptor Proteins 0.000 claims 2
- 102100026894 Lymphotoxin-beta Human genes 0.000 claims 2
- 101150039798 MYC gene Proteins 0.000 claims 2
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 2
- 102100039337 NF-kappa-B inhibitor alpha Human genes 0.000 claims 2
- 102100023059 Nuclear factor NF-kappa-B p100 subunit Human genes 0.000 claims 2
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 claims 2
- 102100021079 Ornithine decarboxylase Human genes 0.000 claims 2
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 claims 2
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 claims 2
- 102100028960 Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Human genes 0.000 claims 2
- 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 claims 2
- 108010064209 Phosphoribosylglycinamide formyltransferase Proteins 0.000 claims 2
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 claims 2
- 102100040681 Platelet-derived growth factor C Human genes 0.000 claims 2
- 102100024028 Progonadoliberin-1 Human genes 0.000 claims 2
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 claims 2
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 claims 2
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 claims 2
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 claims 2
- 102100034253 Retinoic acid receptor RXR-beta Human genes 0.000 claims 2
- 102100023606 Retinoic acid receptor alpha Human genes 0.000 claims 2
- 102100029329 Somatostatin receptor type 1 Human genes 0.000 claims 2
- 101000874827 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) Dephospho-CoA kinase Proteins 0.000 claims 2
- 102100036407 Thioredoxin Human genes 0.000 claims 2
- 102100031208 Thioredoxin reductase 1, cytoplasmic Human genes 0.000 claims 2
- 102100034838 Thymidine kinase, cytosolic Human genes 0.000 claims 2
- 102100038618 Thymidylate synthase Human genes 0.000 claims 2
- 102100040247 Tumor necrosis factor Human genes 0.000 claims 2
- 102100022156 Tumor necrosis factor receptor superfamily member 3 Human genes 0.000 claims 2
- 102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 claims 2
- 102100038232 Vascular endothelial growth factor C Human genes 0.000 claims 2
- 208000008383 Wilms tumor Diseases 0.000 claims 2
- 101100459258 Xenopus laevis myc-a gene Proteins 0.000 claims 2
- 108010080146 androgen receptors Proteins 0.000 claims 2
- 238000002509 fluorescent in situ hybridization Methods 0.000 claims 2
- 102000006815 folate receptor Human genes 0.000 claims 2
- 108020005243 folate receptor Proteins 0.000 claims 2
- 238000013388 immunohistochemistry analysis Methods 0.000 claims 2
- 201000008026 nephroblastoma Diseases 0.000 claims 2
- 108010060054 peroxisome-proliferator-activated receptor-gamma coactivator-1 Proteins 0.000 claims 2
- 102000003998 progesterone receptors Human genes 0.000 claims 2
- 108090000468 progesterone receptors Proteins 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 108010082379 somatostatin receptor type 1 Proteins 0.000 claims 2
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 claims 1
- 102000053723 Angiotensin-converting enzyme 2 Human genes 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 101000852559 Homo sapiens Thioredoxin Proteins 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010061336 Pelvic neoplasm Diseases 0.000 claims 1
- 208000002517 adenoid cystic carcinoma Diseases 0.000 claims 1
- 201000009613 breast lymphoma Diseases 0.000 claims 1
- 230000000973 chemotherapeutic effect Effects 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000003054 hormonal effect Effects 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 208000022013 kidney Wilms tumor Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 210000000651 myofibroblast Anatomy 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 201000007416 salivary gland adenoid cystic carcinoma Diseases 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74764506P | 2006-05-18 | 2006-05-18 | |
| US60/747,645 | 2006-05-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511252A Division JP2009537154A (ja) | 2006-05-18 | 2007-05-18 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015153083A Division JP6129251B2 (ja) | 2006-05-18 | 2015-08-03 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013127477A JP2013127477A (ja) | 2013-06-27 |
| JP2013127477A5 true JP2013127477A5 (enExample) | 2014-06-05 |
Family
ID=38724046
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511252A Pending JP2009537154A (ja) | 2006-05-18 | 2007-05-18 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2013029661A Withdrawn JP2013127477A (ja) | 2006-05-18 | 2013-02-19 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2015153083A Active JP6129251B2 (ja) | 2006-05-18 | 2015-08-03 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2017078333A Active JP6568551B2 (ja) | 2006-05-18 | 2017-04-11 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2019142983A Pending JP2020005641A (ja) | 2006-05-18 | 2019-08-02 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2021212100A Pending JP2022050488A (ja) | 2006-05-18 | 2021-12-27 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2023118742A Pending JP2023139147A (ja) | 2006-05-18 | 2023-07-21 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511252A Pending JP2009537154A (ja) | 2006-05-18 | 2007-05-18 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015153083A Active JP6129251B2 (ja) | 2006-05-18 | 2015-08-03 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2017078333A Active JP6568551B2 (ja) | 2006-05-18 | 2017-04-11 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2019142983A Pending JP2020005641A (ja) | 2006-05-18 | 2019-08-02 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2021212100A Pending JP2022050488A (ja) | 2006-05-18 | 2021-12-27 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| JP2023118742A Pending JP2023139147A (ja) | 2006-05-18 | 2023-07-21 | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (7) | US8700335B2 (enExample) |
| EP (2) | EP3399450A1 (enExample) |
| JP (7) | JP2009537154A (enExample) |
| KR (1) | KR101356305B1 (enExample) |
| CN (2) | CN103424541B (enExample) |
| AU (1) | AU2007253740A1 (enExample) |
| BR (1) | BRPI0711011A2 (enExample) |
| CA (1) | CA2651995C (enExample) |
| CO (1) | CO6141496A2 (enExample) |
| IL (8) | IL301804A (enExample) |
| MX (1) | MX2008014608A (enExample) |
| RU (1) | RU2008146868A (enExample) |
| WO (1) | WO2007137187A2 (enExample) |
| ZA (1) | ZA200809783B (enExample) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1848414T3 (pl) | 2005-02-03 | 2011-10-31 | Wyeth Llc | Sposób leczenia nowotworu opornego na gefitinib |
| WO2007056118A1 (en) | 2005-11-04 | 2007-05-18 | Wyeth | Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
| EP3399450A1 (en) | 2006-05-18 | 2018-11-07 | Caris MPI, Inc. | System and method for determining individualized medical intervention for a disease state |
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
| US8768629B2 (en) | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| US20080280777A1 (en) * | 2007-05-11 | 2008-11-13 | Translational Genomics Research Institute | Method for determining the effects of external stimuli on biological pathways in living cells |
| US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| EP2245460B1 (en) * | 2008-01-25 | 2013-12-25 | Berg LLC | Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy |
| CN107092770A (zh) | 2008-05-12 | 2017-08-25 | 皇家飞利浦电子股份有限公司 | 医学分析系统 |
| CA2725598C (en) | 2008-06-17 | 2013-10-08 | Wyeth Llc | Antineoplastic combinations containing hki-272 and vinorelbine |
| SMT201700084T1 (it) | 2008-08-04 | 2017-03-08 | Wyeth Llc | Associazioni antineoplastiche di 4-anilino-3-cianochinoline e capecitabina |
| EP3216874A1 (en) | 2008-09-05 | 2017-09-13 | TOMA Biosciences, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| US20100069298A1 (en) * | 2008-09-16 | 2010-03-18 | Robert Penny | Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same |
| EP2347009A4 (en) * | 2008-10-14 | 2012-05-30 | Caris Mpi Inc | GENE AND GENE EXPRESSED TARGET PROTEINS FOR THE PRESENTATION OF BIOMARKERS AND SIGNATURES BY TUMOR TYPE |
| FR2937801B1 (fr) * | 2008-10-23 | 2010-12-03 | Souriau | Ensemble de connexion a verrouillage rapide et procede d'accouplement et de desaccouplement de l'ensemble |
| CN107254538A (zh) | 2008-11-12 | 2017-10-17 | 卡里斯生命科学瑞士控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
| PT3301446T (pt) * | 2009-02-11 | 2020-07-14 | Caris Mpi Inc | Perfilagem molecular de tumores |
| HUE061640T2 (hu) | 2009-04-06 | 2023-07-28 | Wyeth Llc | Gyógykezelési rendszer mellrákhoz neratinib alkalmazásával |
| WO2010118782A1 (en) * | 2009-04-17 | 2010-10-21 | Universite Libre De Bruxelles | Methods and tools for predicting the efficiency of anthracyclines in cancer |
| CN106228017A (zh) * | 2009-09-30 | 2016-12-14 | 帕斯维基因组学公司 | 基于基因组的药物管理系统 |
| JP6126382B2 (ja) * | 2010-01-13 | 2017-05-10 | ワイス・エルエルシー | 腫瘍を正確に識別し、かつＰＡＮ‐ＥｒｂＢ阻害剤に対する薬物応答を予測するＰＴＥＮタンパク質発現におけるカットポイント |
| AU2011223789A1 (en) | 2010-03-01 | 2012-09-20 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| FI20105252A0 (fi) | 2010-03-12 | 2010-03-12 | Medisapiens Oy | Menetelmä, järjestely ja tietokoneohjelmatuote biologisen tai lääketieteellisen näytteen analysoimiseen |
| BR112012025593A2 (pt) | 2010-04-06 | 2019-06-25 | Caris Life Sciences Luxembourg Holdings | biomarcadores em circulação para doença |
| CN101984070B (zh) * | 2010-09-21 | 2013-04-24 | 广州益善生物技术有限公司 | 一种c-KIT基因突变检测液相芯片 |
| US9309556B2 (en) | 2010-09-24 | 2016-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target DNA using immobilized primers |
| JP6367557B2 (ja) * | 2011-01-07 | 2018-08-01 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 臨床データ解析モジュールへの統合的なアクセスおよび臨床データ解析モジュールとの相互作用 |
| US20130339060A1 (en) * | 2011-02-17 | 2013-12-19 | University Hospitals Of Cleveland | Method and system for extraction and analysis of inpatient and outpatient encounters from one or more healthcare related information systems |
| EP2681709A4 (en) * | 2011-03-04 | 2015-05-06 | Kew Group Llc | PERSONALIZED MEDICAL MANAGEMENT SYSTEM, NETWORKS AND ASSOCIATED METHODS |
| WO2014019181A1 (zh) * | 2012-08-01 | 2014-02-06 | 华为技术有限公司 | 一种控制信道传输方法及装置 |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| CN110872617A (zh) | 2012-09-04 | 2020-03-10 | 夸登特健康公司 | 检测稀有突变和拷贝数变异的系统和方法 |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US10942184B2 (en) | 2012-10-23 | 2021-03-09 | Caris Science, Inc. | Aptamers and uses thereof |
| CN103784465B (zh) * | 2012-11-02 | 2015-11-11 | 上海交通大学医学院附属瑞金医院 | 乙醛脱氢酶2作为蒽环类化疗药物处理肿瘤细胞时药物靶标的应用 |
| KR101449418B1 (ko) * | 2012-12-27 | 2014-10-14 | 한국식품연구원 | 비만에 대한 영양 유전체 정보를 제공하는 방법 및 이를 이용한 장치 |
| CN105144179B (zh) * | 2013-01-29 | 2019-05-17 | 分子健康股份有限公司 | 用于临床决策支持的系统和方法 |
| CN104630055A (zh) * | 2013-11-08 | 2015-05-20 | 西安科技大学 | 原位杂交系统的主控板 |
| ES2784450T3 (es) | 2013-12-28 | 2020-09-25 | Guardant Health Inc | Métodos y sistemas para detectar variantes genéticas |
| CA2946538A1 (en) | 2014-04-04 | 2015-10-08 | Del Mar Pharmaceuticals | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer |
| CN105512508B (zh) * | 2014-09-22 | 2018-05-15 | 深圳华大基因研究院 | 自动生成基因检测报告的方法及装置 |
| US9983026B2 (en) * | 2014-09-25 | 2018-05-29 | Texas Instruments Incorporated | Multi-level rotational resolvers using inductive sensors |
| IL282614B2 (en) | 2015-02-06 | 2024-02-01 | Cell Idx Inc | Antigen-conjugated immune reagents |
| CA2991045A1 (en) | 2015-06-29 | 2017-01-05 | Caris Science, Inc. | Therapeutic oligonucleotides binding c1q |
| WO2017019918A1 (en) | 2015-07-28 | 2017-02-02 | Caris Science, Inc. | Targeted oligonucleotides |
| JP2018532992A (ja) * | 2015-09-09 | 2018-11-08 | ソマロジック, インコーポレイテッドSomaLogic, Inc. | 個別化薬物治療計画の開発方法、及びプロテオミックプロファイルに基づく標的薬物開発 |
| EP3390668A4 (en) | 2015-12-17 | 2020-04-01 | Guardant Health, Inc. | METHODS OF DETERMINING THE NUMBER OF TUMOR GENE COPIES BY ACELLULAR DNA ANALYSIS |
| KR102393306B1 (ko) * | 2016-01-18 | 2022-04-29 | 줄리안 고프 | 유전자형으로부터 표현형을 결정하는 방법 |
| WO2017139592A1 (en) | 2016-02-12 | 2017-08-17 | Genosecurity, LLC | Security enhanced portable data store and processor for allowing secure and selective access to genomic data |
| JP2019516393A (ja) | 2016-03-18 | 2019-06-20 | カリス サイエンス インコーポレイテッド | オリゴヌクレオチドプローブおよびその使用 |
| IL306052A (en) | 2016-05-25 | 2023-11-01 | Caris Science Inc | Oligonucleotide probes and their uses |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| ES2840003T3 (es) | 2016-09-30 | 2021-07-06 | Guardant Health Inc | Métodos para análisis multi-resolución de ácidos nucleicos libres de células |
| CN106650256B (zh) * | 2016-12-20 | 2020-01-03 | 安徽安龙基因科技有限公司 | 一种分子诊疗精准医学平台 |
| JP2021501333A (ja) * | 2017-10-27 | 2021-01-14 | フロンティア ダイアグノスティクス リミテッド ライアビリティ カンパニー | がん腫評価のための質量分析方法 |
| US11227692B2 (en) * | 2017-12-28 | 2022-01-18 | International Business Machines Corporation | Neuron model simulation |
| CN119753091A (zh) | 2018-04-02 | 2025-04-04 | 格里尔公司 | 用于扩增与癌症相关联的cfDNA分子的化验板 |
| JP6920251B2 (ja) | 2018-06-29 | 2021-08-18 | シスメックス株式会社 | 解析方法、情報処理装置、プログラム |
| WO2020069350A1 (en) | 2018-09-27 | 2020-04-02 | Grail, Inc. | Methylation markers and targeted methylation probe panel |
| US10978196B2 (en) | 2018-10-17 | 2021-04-13 | Tempus Labs, Inc. | Data-based mental disorder research and treatment systems and methods |
| CN109584958A (zh) * | 2018-11-29 | 2019-04-05 | 江苏医联生物科技有限公司 | 一种基于云计算基因序列数据质控管理方法 |
| EP4369356A3 (en) | 2018-11-30 | 2024-07-24 | Caris MPI, Inc. | Next-generation molecular profiling |
| KR102217060B1 (ko) * | 2019-01-30 | 2021-02-18 | (주)메디젠휴먼케어 | 개인별 단일염기 다형성 분석 및 관리 장치 |
| CN113661249B (zh) | 2019-01-31 | 2025-07-01 | 夸登特健康公司 | 用于分离无细胞dna的组合物和方法 |
| AU2020326626A1 (en) | 2019-08-02 | 2022-03-10 | Tempus Ai, Inc. | Data-based mental disorder research and treatment systems and methods |
| JP2021069284A (ja) * | 2019-10-29 | 2021-05-06 | 国立研究開発法人国立循環器病研究センター | 脳梗塞治療支援システム |
| AU2020397802A1 (en) | 2019-12-02 | 2022-06-16 | Caris Mpi, Inc. | Pan-cancer platinum response predictor |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11872049B2 (en) * | 2020-06-10 | 2024-01-16 | Shane Harrah | System and method for detecting presence of illness symptoms |
| WO2022060976A1 (en) * | 2020-09-17 | 2022-03-24 | The Broad Institute, Inc. | Methods for treating infections |
| WO2024086238A1 (en) * | 2022-10-19 | 2024-04-25 | Net/Bio, Inc. | Methods and systems for assessing dose-dependent response of a subject to an intervention |
Family Cites Families (199)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4725550A (en) | 1984-01-19 | 1988-02-16 | Research Foundation Of State University Of New York | Novel mutation of the c-K-ras oncogene activated in a human lung carcinoma |
| IL82930A (en) | 1984-07-19 | 1988-04-29 | Channa Shalitin | Antibodies for the detection of mammalian carcinomas and their preparation |
| US4957859A (en) | 1988-02-16 | 1990-09-18 | Hoffmann-La Roche Inc. | Antibodies for transforming ras protein |
| US6013431A (en) | 1990-02-16 | 2000-01-11 | Molecular Tool, Inc. | Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators |
| US6221620B1 (en) | 1991-04-24 | 2001-04-24 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies specific for human thymidylate synthase |
| EP0655090B1 (en) | 1992-04-27 | 2000-12-27 | The Trustees Of Dartmouth College | Detection of gene sequences in biological fluids |
| US6498144B1 (en) | 1993-10-18 | 2002-12-24 | North Shore - Long Island Jewish Research Institute | Use of scatter factor to enhance angiogenesis |
| US5610281A (en) | 1994-05-03 | 1997-03-11 | Brigham & Women's Hospital, Inc. | Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes |
| US5710001A (en) | 1994-08-12 | 1998-01-20 | Myriad Genetics, Inc. | 17q-linked breast and ovarian cancer susceptibility gene |
| DE69524182T3 (de) | 1994-08-12 | 2009-07-09 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Nukleinsäuresonden umfassend ein Fragment des 17Q-verbundenen Ovarial- und Brustkrebs Empfindlichkeitsgens |
| US5747282A (en) | 1994-08-12 | 1998-05-05 | Myraid Genetics, Inc. | 17Q-linked breast and ovarian cancer susceptibility gene |
| PT705903E (pt) | 1994-08-12 | 2001-11-30 | Myriad Genetics Inc | Mutacoes no gene de susceptibilidade para o cancro da mama e do ovario ligado a 17q |
| US5693473A (en) | 1994-08-12 | 1997-12-02 | Myriad Genetics, Inc. | Linked breast and ovarian cancer susceptibility gene |
| US5753441A (en) | 1994-08-12 | 1998-05-19 | Myriad Genetics, Inc. | 170-linked breast and ovarian cancer susceptibility gene |
| GB9422814D0 (en) | 1994-11-11 | 1995-01-04 | Medinnova Sf | Chemical method |
| US6143737A (en) | 1995-06-23 | 2000-11-07 | Georgetown University | Progesterone analogs to reverse multidrug resistance |
| NO954667D0 (no) | 1995-11-17 | 1995-11-17 | Dagfinn Oegreid | Fremgangsmåte til deteksjon av Ki-ras mutasjoner |
| US5998151A (en) | 1995-12-01 | 1999-12-07 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for predicting the efficacy of a chemotherapeutic regimen for gastrointestinal cancers using antibodies specific for thymidylate synthase |
| WO1997022689A1 (en) | 1995-12-18 | 1997-06-26 | Myriad Genetics, Inc. | Chromosome 13-linked breast cancer susceptibility gene |
| US5837492A (en) | 1995-12-18 | 1998-11-17 | Myriad Genetics, Inc. | Chromosome 13-linked breast cancer susceptibility gene |
| US5942385A (en) | 1996-03-21 | 1999-08-24 | Sugen, Inc. | Method for molecular diagnosis of tumor angiogenesis and metastasis |
| US5895748A (en) | 1996-11-27 | 1999-04-20 | Johnson; Keith R. | Panel of antibodies for detecting cadherins and catenins in tissues and method of using the panel of antibodies |
| US6262242B1 (en) | 1997-01-30 | 2001-07-17 | Board Of Regents, The University Of Texas System | Tumor suppressor designated TS10Q23.3 |
| US6482795B1 (en) | 1997-01-30 | 2002-11-19 | Myriad Genetics, Inc. | Tumor suppressor designated TS10q23.3 |
| WO1998033518A1 (en) | 1997-02-04 | 1998-08-06 | Sloan-Kettering Institute For Cancer Research | Mutants of thymidylate synthase and uses thereof |
| US6150514A (en) | 1997-04-09 | 2000-11-21 | University Of Utah Research Foundation | 14 Kilobase deletion in the promoter region of BRCA1 in a breast cancer family |
| GB9715034D0 (en) | 1997-07-18 | 1997-09-24 | Zeneca Ltd | Assay |
| JP2002505431A (ja) * | 1998-02-25 | 2002-02-19 | アメリカ合衆国 | 迅速な分子プロファイリングのための細胞アッセイ法 |
| US6218122B1 (en) * | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| EP1388734B1 (en) | 2002-08-01 | 2004-03-03 | MTM Laboratories AG | Method for solution based diagnosis |
| EP1131470A4 (en) * | 1998-10-28 | 2004-11-10 | Vysis Inc | CELLULAR NETWORKS AND METHODS FOR DETECTION AND USE OF GENETIC DISORDER MARKERS |
| EP1151300B1 (en) | 1998-12-23 | 2010-04-28 | Medsaic Pty Limited | An assay to detect a binding partner |
| US6613510B2 (en) | 1999-04-28 | 2003-09-02 | Mayo Foundation For Medical Education And Research | Methods and probe sets for determining prostate cancer prognosis |
| DE19922052A1 (de) | 1999-05-14 | 2000-11-16 | Theragen Molekularmedizinische | Verfahren zum Nachweis der Wirkung von unterschiedlichen Chemotherapeutika und/oder einer Strahlentherapie bei malignen Erkrankungen sowie Verfahren zur Auswahl wirkungsvoller therapeutischer Mittel zu deren Therapie |
| KR100543857B1 (ko) | 1999-09-01 | 2006-01-23 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 |
| US6586177B1 (en) | 1999-09-08 | 2003-07-01 | Exact Sciences Corporation | Methods for disease detection |
| US7135303B2 (en) | 2000-02-28 | 2006-11-14 | The United States Of America As Represented By The Department Of Health And Human Services | Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| JP2004505612A (ja) | 2000-03-31 | 2004-02-26 | ユニバーシティ・オブ・サザン・カリフォルニア | 食道腺ガンに関する後成的配列 |
| US6812023B1 (en) | 2000-04-27 | 2004-11-02 | Anosys, Inc. | Methods of producing membrane vesicles |
| EP1158055A1 (fr) | 2000-05-26 | 2001-11-28 | Xu Qi University of Teaxs Laboratoire de Leucémie Chen | Méthode pour le diagnostic de cancers |
| WO2001092338A1 (en) | 2000-06-01 | 2001-12-06 | The Brigham And Women's Hospital, Inc. | Diagnosis of endometrial precancers |
| AU2001277172A1 (en) | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-trans protein and related reagents and methods of use thereof |
| CA2420176A1 (en) * | 2000-08-24 | 2002-02-28 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| KR20030029847A (ko) * | 2000-08-24 | 2003-04-16 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 조성물 및 방법 |
| CA2420193A1 (en) * | 2000-08-24 | 2002-02-28 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| DE10043591A1 (de) | 2000-09-01 | 2002-03-14 | Max Delbrueck Centrum | Verfahren zur Erfassung von Resistenz-Profilen von Geweben und Zellinien |
| US7711580B1 (en) * | 2000-10-31 | 2010-05-04 | Emergingmed.Com | System and method for matching patients with clinical trials |
| WO2002044715A1 (en) | 2000-11-28 | 2002-06-06 | Surromed, Inc. | Methods for efficiently minig broad data sets for biological markers |
| US20020142328A1 (en) | 2000-12-01 | 2002-10-03 | Danenberg Kathleen D. | Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
| US7049059B2 (en) | 2000-12-01 | 2006-05-23 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| CA2432976A1 (en) | 2000-12-21 | 2002-08-08 | Board Of Trustees Of The University Of Illinois | Reagents and methods for identifying and modulating expression of tumor senescence genes |
| US20020150966A1 (en) * | 2001-02-09 | 2002-10-17 | Muraca Patrick J. | Specimen-linked database |
| CA2377213A1 (en) | 2001-03-20 | 2002-09-20 | Ortho-Clinical Diagnostics, Inc. | Method for providing clinical diagnostic services |
| EP1411120B1 (en) | 2001-07-05 | 2010-01-13 | Taiho Pharmaceutical Company Limited | Dna arrays for measuring sensitivity to anticancer agent |
| US20030013120A1 (en) | 2001-07-12 | 2003-01-16 | Patz Edward F. | System and method for differential protein expression and a diagnostic biomarker discovery system and method using same |
| CN1408883A (zh) * | 2001-09-30 | 2003-04-09 | 上海博德基因开发有限公司 | 一种基于基因芯片进行抗肿瘤药物筛选的方法 |
| US7504222B2 (en) | 2001-10-31 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| EP1456364B1 (en) | 2001-12-21 | 2011-03-23 | The Wellcome Trust | Mutations in the b-raf gene |
| WO2003061564A2 (en) * | 2001-12-21 | 2003-07-31 | Gene Logic, Inc. | Gene expression profiles in liver disease |
| JP2005532036A (ja) * | 2002-01-09 | 2005-10-27 | 理化学研究所 | 癌プロフィール |
| JP3481231B2 (ja) | 2002-03-05 | 2003-12-22 | 三洋電機株式会社 | 有機エレクトロルミネッセンス表示装置およびその製造方法 |
| EP3115470B1 (en) | 2002-03-13 | 2018-07-18 | Genomic Health, Inc. | Gene expression profiling in biopsied tumor tissues |
| WO2003104474A2 (en) | 2002-06-07 | 2003-12-18 | Myriad Genetics, Inc | Large deletions in human brca1 gene and use thereof |
| AT500648B1 (de) | 2002-08-12 | 2010-03-15 | Igeneon Krebs Immuntherapie | Set zur behandlung von krebspatienten |
| US20060008807A1 (en) | 2002-08-23 | 2006-01-12 | O'hara Shawn M | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
| WO2004024892A2 (en) * | 2002-09-12 | 2004-03-25 | Chondrogene Inc. | Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
| AU2003303144A1 (en) * | 2002-10-18 | 2004-07-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| CA2504605C (en) | 2002-11-13 | 2016-01-19 | Thomas Jefferson University | Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15 |
| US20050283386A1 (en) * | 2002-11-20 | 2005-12-22 | Aventis Pharmaceuticals Inc. | Method and system for marketing a treatment regimen |
| US7643943B2 (en) | 2003-02-11 | 2010-01-05 | Wyeth Llc | Methods for monitoring drug activities in vivo |
| WO2004074518A1 (en) | 2003-02-20 | 2004-09-02 | Genomic Health, Inc. | Use of intronic rna to measure gene expression |
| NZ587776A (en) | 2003-04-09 | 2012-03-30 | Genentech Inc | Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor using anti-CD20 antibody |
| US7361460B2 (en) | 2003-04-11 | 2008-04-22 | Digene Corporation | Approach to molecular diagnosis of human papillomavirus-related diseases |
| US20050084913A1 (en) | 2003-04-22 | 2005-04-21 | Maxygen, Inc. | Novel tumor-associated antigens |
| US8150627B2 (en) | 2003-05-15 | 2012-04-03 | Illumina, Inc. | Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns |
| US20070105105A1 (en) | 2003-05-23 | 2007-05-10 | Mount Sinai School Of Medicine Of New York University | Surrogate cell gene expression signatures for evaluating the physical state of a subject |
| JP2007506442A (ja) | 2003-05-30 | 2007-03-22 | ゲノミック ヘルス， インコーポレイテッド | Ｅｇｆｒ阻害薬への応答に関する遺伝子発現マーカー |
| KR20060031809A (ko) | 2003-06-09 | 2006-04-13 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 암 치료 및 진단용 조성물 및 방법 |
| US7319007B2 (en) | 2003-06-12 | 2008-01-15 | Pomeranian Academy Of Medicine | Determining a predisposition to cancer |
| CA2528529A1 (en) | 2003-06-20 | 2004-12-29 | Amgen Inc. | Gene amplification and overexpression in cancer |
| HUE050365T2 (hu) | 2003-06-24 | 2022-09-28 | Genomic Health Inc | Rákkiújulás valószínûségének elõrejelzése |
| ES2905579T3 (es) | 2003-07-10 | 2022-04-11 | Genomic Health Inc | Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama |
| EP1980629A3 (en) | 2003-08-28 | 2008-12-17 | Ipsogen | Identification of an erbb2 gene expression signature in breast cancers |
| WO2005031002A2 (en) | 2003-09-22 | 2005-04-07 | Rosetta Inpharmatics Llc | Synthetic lethal screen using rna interference |
| CA2540894A1 (en) * | 2003-10-03 | 2005-04-14 | Bayer Pharmaceuticals Corporation | Gene expression profiles and methods of use |
| EP1756137A4 (en) | 2003-11-05 | 2007-10-31 | Univ Texas | DIAGNOSTIC AND THERAPEUTIC PROCEDURES AND COMPOSITIONS CONCERNING PTEN AND BREAST CANCER |
| EP1538219A1 (en) | 2003-12-04 | 2005-06-08 | Erasmus University Medical Center Rotterdam | Method to diagnose or screen for type 1 diabetes mellitus |
| CA2549518A1 (en) | 2003-12-12 | 2005-07-14 | University Of Rochester | Non-androgen dependent roles for androgen receptor and non-androgen related inhibitors of androgen receptor |
| US20050221398A1 (en) * | 2004-01-16 | 2005-10-06 | Ipsogen, Sas, A Corporation Of France | Protein expression profiling and breast cancer prognosis |
| EP1711632A4 (en) | 2004-01-19 | 2009-03-11 | Technion Res & Dev Foundation | DIAGNOSTIC TEST FOR PARKINSON |
| US20050181377A1 (en) * | 2004-02-13 | 2005-08-18 | Markovic Svetomir N. | Targeted cancer therapy |
| WO2005092038A2 (en) | 2004-03-22 | 2005-10-06 | The Johns Hopkins University | Methods for the detection of nucleic acid differences |
| WO2005094830A1 (en) | 2004-03-30 | 2005-10-13 | Pfizer Products Inc. | Combinations of signal transduction inhibitors |
| CN107988363A (zh) | 2004-03-31 | 2018-05-04 | 综合医院公司 | 测定癌症对表皮生长因子受体靶向性治疗反应性的方法 |
| DK2163650T3 (en) | 2004-04-09 | 2015-11-02 | Genomic Health Inc | Genekspressionsmarkører for prediction of response to chemotherapy |
| US8420603B2 (en) | 2004-05-14 | 2013-04-16 | Abraxis Bioscience, Llc | SPARC and methods of use thereof |
| US8135595B2 (en) | 2004-05-14 | 2012-03-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Computer systems and methods for providing health care |
| EP1784501B1 (en) | 2004-05-14 | 2015-11-18 | Rosetta Genomics Ltd | VIRAL AND VIRUS ASSOCIATED MicroRNAS AND USES THEREOF |
| EP1751309B1 (en) | 2004-05-27 | 2015-07-22 | The Regents of The University of Colorado | Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients |
| JP2008501336A (ja) | 2004-06-02 | 2008-01-24 | ソースフアーム・インコーポレイテツド | Ｒｎａを含有する微小胞およびそのための方法 |
| CA2569502A1 (en) | 2004-06-04 | 2005-12-15 | Veridex Llc | Diagnosing or predicting the course of breast cancer |
| US20060018897A1 (en) | 2004-06-28 | 2006-01-26 | Transtarget Inc. | Bispecific antibodies |
| EP3342877B1 (en) | 2004-09-30 | 2020-01-29 | Epigenomics AG | Method for providing dna fragments derived from an archived sample |
| WO2006050475A2 (en) | 2004-11-03 | 2006-05-11 | Brigham And Women's Hospital, Inc. | Identification of dysregulated genes in patients with neurological diseases |
| CA2587765A1 (en) | 2004-11-17 | 2006-05-26 | Immunivest Corporation | Magnetic enrichment of circulating cells, fragments and debris for enabling hts proteomics and genomics in disease detection |
| US7862995B2 (en) | 2004-12-10 | 2011-01-04 | Targeted Molecular Diagnostics | Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor |
| US7442507B2 (en) | 2005-01-24 | 2008-10-28 | New York University School Of Medicine | Methods for detecting circulating mutant BRAF DNA |
| WO2006087233A2 (en) | 2005-02-21 | 2006-08-24 | Max-Planck-Gesellschaft zur Förderung der Wissenschaft e.V. | Release of extracellular membrane particles carrying the stem cell marker prominin-1 (cd133) from neural progenitors and other epithelial cells |
| WO2006098978A1 (en) | 2005-03-09 | 2006-09-21 | Abbott Laboratories | Diagnostics method for identifying candidate patients for the treatment with trastuzumab |
| AU2006234897A1 (en) | 2005-03-16 | 2006-10-19 | Sidney Kimmel Cancer Center | Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures |
| WO2006113747A2 (en) | 2005-04-19 | 2006-10-26 | Prediction Sciences Llc | Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| US20090061422A1 (en) | 2005-04-19 | 2009-03-05 | Linke Steven P | Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| EP1722231A3 (en) | 2005-04-27 | 2009-03-11 | MPB MelTec Patent- und Beteiligungsgesellschaft mbH | Method for identification of somatic stem cells |
| WO2006121991A2 (en) | 2005-05-06 | 2006-11-16 | Diadexus, Inc. | Compositions and methods for detection, prognosis and treatment of breast cancer |
| US20070020657A1 (en) | 2005-05-20 | 2007-01-25 | Grebe Stefan K | Methods for detecting circulating tumor cells |
| US20070099209A1 (en) | 2005-06-13 | 2007-05-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2007001868A1 (en) | 2005-06-28 | 2007-01-04 | Genentech, Inc. | Egfr and kras mutations |
| US20070134687A1 (en) | 2005-09-12 | 2007-06-14 | Aurelium Biopharma Inc. | Focused microarray and methods of diagnosing cancer |
| JP2009509171A (ja) | 2005-09-21 | 2009-03-05 | シーシーシー ダイアグノスティックス， エルエルシー | 個別化抗癌化学療法（ｐａｃ）のための包括的な診断試験 |
| CA2624086A1 (en) | 2005-09-28 | 2007-04-05 | H. Lee Moffitt Cancer Center | Individualized cancer treatments |
| US20090226902A1 (en) | 2005-10-12 | 2009-09-10 | Hemmo Arjan Drexhage | Method to Diagnose or Screen for Inflammatory Diseases |
| ES2324435B1 (es) | 2005-10-27 | 2010-05-31 | Fundacion Para El Estudio De La Hematologia Y Hemoterapia De Aragon (Fehha) | Procedimiento y dispositivo de analisis in vitro de mrna de genes implicados en neoplasias hematologicas. |
| EP1945754B1 (en) | 2005-10-31 | 2014-07-23 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US20090215642A1 (en) | 2005-12-09 | 2009-08-27 | Knudson Alfred G | Methods and Compositions for Assessing Alterations in Gene Expression Patterns in Clinically Normal Tissues Obtained from Heterozygous Carriers of Mutant Genes Associated with Cancer and Methods of Use Thereof |
| JP2007175021A (ja) | 2005-12-28 | 2007-07-12 | Sysmex Corp | 大腸がんのリンパ節転移マーカー |
| US7593913B2 (en) | 2006-01-11 | 2009-09-22 | Siemens Medical Solutions Usa, Inc. | Systems and method for integrative medical decision support |
| NZ593224A (en) | 2006-01-11 | 2012-10-26 | Genomic Health Inc | Gene expression markers (fap) for colorectal cancer prognosis |
| CN101410715A (zh) | 2006-01-27 | 2009-04-15 | 三路影像公司 | 鉴定患卵巢癌的可能性增加的患者的方法及其组合物 |
| US8034549B2 (en) | 2006-02-09 | 2011-10-11 | University Of South Florida | Detection of cancer by elevated levels of BCL-2 |
| NZ545243A (en) | 2006-02-10 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Urine gene expression ratios for detection of cancer |
| ES2300176B1 (es) | 2006-02-15 | 2009-05-01 | Consejo Superior Investig. Cientificas | Metodo para el diagnostico molecular de cancer de prostata, kit para implementar el metodo. |
| US20070207489A1 (en) | 2006-02-16 | 2007-09-06 | Pestano Gary A | Reagents and methods for cancer prognosis and pathological staging |
| US20090061454A1 (en) | 2006-03-09 | 2009-03-05 | Brody Jerome S | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
| US7908091B2 (en) | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| BRPI0709340A2 (pt) | 2006-03-27 | 2013-04-16 | Globeimmune Inc | mutaÇço ras e composiÇÕes e mÉtodos de uso da mesma |
| CA2648021A1 (en) | 2006-03-31 | 2007-10-11 | Ordway Research Institute, Inc. | Prognostic and diagnostic method for cancer therapy |
| US20090098538A1 (en) | 2006-03-31 | 2009-04-16 | Glinsky Gennadi V | Prognostic and diagnostic method for disease therapy |
| US7901885B2 (en) | 2006-05-09 | 2011-03-08 | Dsm Ip Assets B.V. | Genes and markers in type 2 diabetes and obesity |
| US8768629B2 (en) | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| EP3399450A1 (en) | 2006-05-18 | 2018-11-07 | Caris MPI, Inc. | System and method for determining individualized medical intervention for a disease state |
| CA2654584A1 (en) | 2006-06-05 | 2007-12-21 | Genentech, Inc. | Extending survival of cancer patients with elevated levels of egf or tgf-alpha |
| US8288369B2 (en) | 2006-06-27 | 2012-10-16 | University Of South Florida | Delta-tocotrienol treatment and prevention of pancreatic cancer |
| US7999080B2 (en) | 2006-07-13 | 2011-08-16 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in signaling pathways |
| US20080014598A1 (en) | 2006-07-13 | 2008-01-17 | Cell Signaling Technology, Inc. | Phospho-specific antibodies to pi3k regulatory subunit and uses thereof |
| CA2657576C (en) | 2006-07-14 | 2023-10-31 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
| WO2008021483A2 (en) | 2006-08-17 | 2008-02-21 | Ordway Research Institute | Prognostic and diagnostic method for disease therapy |
| EP1892303A1 (en) | 2006-08-22 | 2008-02-27 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Methods for identifying therapeutical targets in tumors and for determining and targeting angiogenesis and hemostasis related to adenocarcinomas of the lung |
| US20080118576A1 (en) | 2006-08-28 | 2008-05-22 | Dan Theodorescu | Prediction of an agent's or agents' activity across different cells and tissue types |
| US20090280493A1 (en) | 2006-09-08 | 2009-11-12 | Siemens Healthcare Diagnostics Inc. | Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia |
| RU2009114745A (ru) | 2006-09-19 | 2010-10-27 | Новартис АГ (CH) | Биомаркеры, предназначенные для выявления направленной модуляции, эффективности ингибиторов raf, применения с целью диагностики и/или прогнозирования |
| US7521189B2 (en) | 2006-10-12 | 2009-04-21 | Fair Isaac Corporation | Devices for generating detectable polymers |
| JP2010508512A (ja) | 2006-10-27 | 2010-03-18 | ジョージ メイソン インテレクチュアル プロパティーズ，インコーポレイテッド オブ フェアファックス，バージニア | 転移性結腸直腸癌のアッセイ |
| AU2007328427A1 (en) | 2006-11-06 | 2008-06-12 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring and treatment of melanoma |
| US20100196889A1 (en) | 2006-11-13 | 2010-08-05 | Bankaitis-Davis Danute M | Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer |
| EP2087140A2 (en) | 2006-11-13 | 2009-08-12 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| EP2120909A2 (en) | 2006-12-15 | 2009-11-25 | Ordway Research Institute | Treatments of therapy-resistant diseases comprising drug combinations |
| US9353415B2 (en) | 2006-12-19 | 2016-05-31 | Thomson Reuters (Scientific) Llc | Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom |
| US20080226645A1 (en) | 2007-01-10 | 2008-09-18 | Wyeth | Methods and compositions for assessment and treatment of asthma |
| US8455188B2 (en) | 2007-01-26 | 2013-06-04 | University Of Louisville Research Foundation, Inc. | Modification of exosomal components for use as a vaccine |
| CA2676148A1 (en) | 2007-01-26 | 2008-07-31 | University Of Louisville Research Foundation, Inc. | Methods of detecting autoantibodies for diagnosing and characterizing disorders |
| US8105796B2 (en) | 2007-02-15 | 2012-01-31 | Universita' Degli Studi Di Torino | Regulation of expression of PI3Kβ protein in tumors |
| US9556491B2 (en) | 2007-02-26 | 2017-01-31 | John Wayne Cancer Institute | Utility of B-RAF DNA mutation in diagnosis and treatment of cancer |
| MX2009009379A (es) | 2007-03-02 | 2009-09-14 | Amgen Inc | Metodos y composiciones para tratar enfermedades tumorales. |
| WO2008112283A2 (en) | 2007-03-12 | 2008-09-18 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment |
| AU2008226808B2 (en) | 2007-03-13 | 2013-04-18 | Amgen Inc. | K-ras and B-raf mutations and anti-EGFr antibody therapy |
| HUE033695T2 (en) | 2007-03-13 | 2017-12-28 | Amgen Inc | K-RAS mutations and anti-EGFR antibody therapy |
| US20090258795A1 (en) | 2007-03-15 | 2009-10-15 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| US20080242622A1 (en) | 2007-03-19 | 2008-10-02 | Cold Spring Harbor Laboratory | Identification of genetic alterations that modulate drug sensitivity in cancer treatments |
| EP2155897A2 (en) | 2007-03-30 | 2010-02-24 | Source Precision Medicine, Inc. d/b/a Source MDX. | Gene expression profiling for identification, monitoring, and treatment of prostate cancer |
| WO2008123867A1 (en) | 2007-04-05 | 2008-10-16 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of breast cancer |
| WO2008123866A2 (en) | 2007-04-05 | 2008-10-16 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring and treatment of ovarian cancer |
| WO2008143639A2 (en) | 2007-04-06 | 2008-11-27 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of cervical cancer |
| EP1983002A3 (en) | 2007-04-19 | 2009-03-11 | Peter Hornbeck | Tyrosine phosphorylation sites and antibodies specific for them |
| WO2008138578A2 (en) | 2007-05-11 | 2008-11-20 | Medical Prognosis Institute | Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| WO2008151004A1 (en) | 2007-05-31 | 2008-12-11 | Yale University | A genetic lesion associated with cancer |
| RU2010101093A (ru) | 2007-06-15 | 2011-07-20 | Юниверсити Оф Саут Флорида (Us) | Способы диагностики и лечения рака |
| CA3056116A1 (en) | 2007-06-22 | 2008-12-31 | Randolph Watnick | Methods and uses thereof of prosaposin |
| EP2176665B1 (en) | 2007-08-16 | 2016-03-02 | The Royal Institution for the Advancement of Learning / McGill University | Tumor cell-derived microvesicles |
| US8076061B2 (en) | 2007-09-07 | 2011-12-13 | Ascentgene, Inc. | Method and composition for cancer diagnosis and treatment |
| CA2639416C (en) | 2007-09-11 | 2019-12-31 | F. Hoffmann-La Roche Ag | Diagnostic test for susceptibility to b-raf kinase inhibitors |
| BRPI0816852A2 (pt) | 2007-09-14 | 2017-06-06 | Univ Ohio State Res Found | método de diagnosticar ou prognosticar doença ou desordem em sujeito, biomarcador, método para determinar e/ou prever se sujeito tem diferenciação da desordem, biomarcador para desordem pulmonar, método para diagnosticar se sujeito tem, ou está em risco de desenvolver doença ou desordem, método de inibir a proliferação de doença ou desordem e método para identificar agente terapêutico do câncer. |
| EP2215258A4 (en) | 2007-10-23 | 2010-12-01 | Clinical Genomics Pty Ltd | METHOD FOR DIAGNOSING NEOPLASMS |
| WO2009061297A1 (en) | 2007-11-06 | 2009-05-14 | Source Precision Medicine, Inc. | Gene expression profiling for identification of cancer |
| CA2706881A1 (en) | 2007-11-30 | 2009-06-11 | Brian Z. Ring | Tle3 as a marker for chemotherapy |
| US20090203015A1 (en) | 2008-02-13 | 2009-08-13 | Celera Corporation | Multiplex assays for hormonal and growth factor receptors, and uses thereof |
| WO2009103790A2 (en) | 2008-02-21 | 2009-08-27 | Universite Libre De Bruxelles | Method and kit for the detection of genes associated with pik3ca mutation and involved in pi3k/akt pathway activation in the er-positive and her2-positive subtypes with clinical implications |
| GB0803192D0 (en) | 2008-02-22 | 2008-04-02 | Mubio Products Bv | SCLC biomarker panel |
| ES2600165T3 (es) | 2008-02-28 | 2017-02-07 | The Ohio State University Research Foundation | Antagonistas de miR-32 para aumentar la respuesta del cáncer de próstata a la apoptosis |
| BRPI0906099A2 (pt) | 2008-03-06 | 2015-07-21 | Genentech Inc | "método de tratamento do câncer em um indivíduo" |
| EP2105511A1 (en) | 2008-03-28 | 2009-09-30 | Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. | Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung |
| WO2009124251A1 (en) | 2008-04-03 | 2009-10-08 | Sloan-Kettering Institute For Cancer Research | Gene signatures for the prognosis of cancer |
| WO2009126160A1 (en) | 2008-04-10 | 2009-10-15 | University Of Florida Research Foundation | Compositions and methods for the treatment of prostate carcinoma |
| US20090269773A1 (en) | 2008-04-29 | 2009-10-29 | Nodality, Inc. A Delaware Corporation | Methods of determining the health status of an individual |
| EP2568053B1 (en) | 2008-05-12 | 2014-04-16 | Genomic Health, Inc. | Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| EP3216874A1 (en) | 2008-09-05 | 2017-09-13 | TOMA Biosciences, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| US20100069298A1 (en) | 2008-09-16 | 2010-03-18 | Robert Penny | Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same |
| EP2347009A4 (en) | 2008-10-14 | 2012-05-30 | Caris Mpi Inc | GENE AND GENE EXPRESSED TARGET PROTEINS FOR THE PRESENTATION OF BIOMARKERS AND SIGNATURES BY TUMOR TYPE |
| CA2779843A1 (en) | 2009-11-13 | 2011-05-19 | Infinity Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer |
| AU2011223789A1 (en) | 2010-03-01 | 2012-09-20 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
-
2007
- 2007-05-18 EP EP17210453.1A patent/EP3399450A1/en not_active Ceased
- 2007-05-18 KR KR1020087028343A patent/KR101356305B1/ko active Active
- 2007-05-18 CA CA2651995A patent/CA2651995C/en active Active
- 2007-05-18 CN CN201310356643.5A patent/CN103424541B/zh active Active
- 2007-05-18 BR BRPI0711011-1A patent/BRPI0711011A2/pt not_active Application Discontinuation
- 2007-05-18 AU AU2007253740A patent/AU2007253740A1/en not_active Abandoned
- 2007-05-18 MX MX2008014608A patent/MX2008014608A/es unknown
- 2007-05-18 CN CN2007800180159A patent/CN101449162B/zh active Active
- 2007-05-18 RU RU2008146868/15A patent/RU2008146868A/ru not_active Application Discontinuation
- 2007-05-18 JP JP2009511252A patent/JP2009537154A/ja active Pending
- 2007-05-18 US US11/750,721 patent/US8700335B2/en active Active
- 2007-05-18 WO PCT/US2007/069286 patent/WO2007137187A2/en not_active Ceased
- 2007-05-18 EP EP07783950A patent/EP2032980A4/en not_active Withdrawn
- 2007-05-18 IL IL301804A patent/IL301804A/en unknown
- 2007-05-18 IL IL282783A patent/IL282783B2/en unknown
-
2008
- 2008-11-12 IL IL195266A patent/IL195266A/en active IP Right Grant
- 2008-11-17 ZA ZA2008/09783A patent/ZA200809783B/en unknown
- 2008-11-18 CO CO08122494A patent/CO6141496A2/es unknown
-
2013
- 2013-02-19 JP JP2013029661A patent/JP2013127477A/ja not_active Withdrawn
- 2013-10-11 US US14/052,503 patent/US8831890B2/en active Active
- 2013-12-30 US US14/143,959 patent/US8914239B2/en active Active
-
2014
- 2014-01-08 US US14/150,624 patent/US20140121121A1/en not_active Abandoned
- 2014-01-31 US US14/170,466 patent/US8880350B2/en active Active
- 2014-08-29 US US14/473,881 patent/US9372193B2/en active Active
- 2014-08-29 US US14/473,871 patent/US9383365B2/en active Active
-
2015
- 2015-08-03 JP JP2015153083A patent/JP6129251B2/ja active Active
-
2016
- 2016-01-21 IL IL243717A patent/IL243717A/en active IP Right Grant
- 2016-01-21 IL IL243718A patent/IL243718A/en active IP Right Grant
- 2016-01-21 IL IL243719A patent/IL243719A/en active IP Right Grant
-
2017
- 2017-04-09 IL IL251666A patent/IL251666B/en active IP Right Grant
- 2017-04-11 JP JP2017078333A patent/JP6568551B2/ja active Active
-
2019
- 2019-04-21 IL IL266164A patent/IL266164B/en active IP Right Grant
- 2019-08-02 JP JP2019142983A patent/JP2020005641A/ja active Pending
-
2021
- 2021-12-27 JP JP2021212100A patent/JP2022050488A/ja active Pending
-
2023
- 2023-07-21 JP JP2023118742A patent/JP2023139147A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013127477A5 (enExample) | ||
| RU2008146868A (ru) | Система и способ определения персонализированого медицинского вмешательства при болезненном состоянии | |
| Horak et al. | Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls | |
| Mohan et al. | Profiling of circulating free DNA using targeted and genome-wide sequencing in patients with SCLC | |
| Jamaspishvili et al. | Clinical implications of PTEN loss in prostate cancer | |
| KR20190020649A (ko) | 역형성 림프종 키나아제(alk) 핵산 및 alk 융합 전사물의 혈장 기반 검출 및 암의 진단 및 치료에 있어 이의 용도 | |
| JP2012517238A5 (enExample) | ||
| Köhn et al. | Liquid biopsies in lung cancer—time to implement research technologies in routine care? | |
| JP2012501452A5 (enExample) | ||
| US20230203591A1 (en) | Detection method using eukaryotic cells | |
| US20180066323A1 (en) | Biomarkers in Cancer, Methods, and Systems Related Thereto | |
| Tao et al. | Predicting the response of neoadjuvant therapy for patients with esophageal carcinoma: an in-depth literature review | |
| Talebi et al. | Fusion transcript discovery using RNA sequencing in formalin-fixed paraffin-embedded specimen | |
| JP2009050189A (ja) | 抗癌剤の有効性予測方法 | |
| Hentze et al. | Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project | |
| JP2022528182A (ja) | 神経膠腫の診断用または予後予測用の組成物、及びそれに係わる情報を提供する方法 | |
| ES2916450T3 (es) | Método para la detección de discrasia de células plasmáticas | |
| Wang et al. | Advancement in Multi-omics approaches for Uterine Sarcoma | |
| CN102947446B (zh) | 肺腺癌的预后预测方法、肺腺癌的检测试剂盒以及用于治疗肺腺癌的医药组合物 | |
| Kou et al. | Serum miR-518e-5p is a potential biomarker for secondary imatinib-resistant gastrointestinal stromal tumor | |
| Han et al. | Exploratory study on the correlation between 14 lung cancer-related gene expression and specific clinical characteristics of NSCLC patients | |
| JP2022551488A (ja) | びまん性神経膠腫および治療に対する応答性を評価するための同時マーカー検出の使用 | |
| Chen et al. | Epigenomic Sequencing Technologies | |
| Tikhonov et al. | Diagnostic value of anti-glycan antibodies in patients with colorectal cancer | |
| EP4639165A1 (en) | Assessment of biological samples for nucleic acid analysis |